Cellyan Biotechnology (HKPD) Shares Outstanding (Diluted Average) (2024 - 2025)
Cellyan Biotechnology (HKPD) reported Shares Outstanding (Diluted Average) of $14.0 for Q3 2025, down 83.13% year-over-year from $83.0 in Q3 2024, and down 83.13% quarter-over-quarter from $83.0 in Q3 2024.
Cellyan Biotechnology (HKPD) Shares Outstanding (Diluted Average) (2024 - 2025) Analysis & Trends
Cellyan Biotechnology (HKPD) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $14.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.00 |
| Sep 30, 2024 | 83.00 |